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Rapid Communication 
Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated 
Endocytosis Pathway 
David T. Curiel, Santosh Agarwal, Maria Unni Romer, Ernst Wagner, Matt Cotten, Max L. Birnstiel, and Richard C. Boucher 
Department of Mediane, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of 
General Physiology and Biophysics, University of Copenhagen, Copenhagen, Denmark; 
and Forschungs-Institut für Molekulare Pathologie, Vienna, Austria 
Gene-based therapies for a variety of inherited and acquired pulmonary diseases will require the develop-
ment of vectors capable of safe and efficient transfer of DNA to the respiratory epithelium. The present 
study examined the feasibility of delivering DNA to respiratory epithelial cells by the receptor-mediated 
endocytosis pathway. This strategy employs molecular conjugates consisting of a cognate moiety, in this 
case human transferrin, covalently linked to a DNA-binding moiety, such as a cationic polyamine. Com-
plexes were formed between transferrin-polylysine conjugates (hTfpL) and plasmid DNA carrying the 
firefly luciferase reporter gene (pRSVL). The conjugate-DNA complexes were added directly to cells in 
tissue culture and incubated for 24 h, after which cell lysates were analyzed for luciferase enzyme activity 
by luminometry. An immortalized human respiratory epithelial cell line (HBE1) treated with the 
transferrin-polylysine-DNA complexes exhibited luciferase enzyme activity significantly augmented over 
background levels. This respiratory epithelial cell line exhibited greater susceptibility to gene transfer 
by the transferrin-polylysine conjugates than did non-respiratory epithelial cell lines known to possess 
high levels of transferrin receptors. Eflfective gene transfer was shown to require both the DNA-binding 
moiety and cognate moiety for the cell surface receptor. Specific internalization of the conjugates by the 
tranferrin pathway was verified by competition for the transferrin receptor. In addition, treatment with 
agents that either increased transferrin receptor number or decreased lysosomal degradation markedly 
augmented gene expression mediated by the conjugates. Thus, respiratory epithelial cells possess recep-
tors for transferrin that can be exploited to accomplish gene transfer by the receptor-mediated endocytosis 
pathway. 
A variety of inherited and acquired disorders affecting the 
cells of the respiratory epithelium may potentially be ap-
proached utilizing therapies directed at the level of gene ex-
pression. In this regard, the gene mutations etiologic of the 
inherited pulmonary disorders c*,-antitrypsin deficiency (1) 
and cystic fibrosis (2) have been defined and phenotypic cor-
rection accomplished at the cell or organ level by means of 
transfer of normal gene counterparts to cells of the respira-
tory epithelium (3, 4). Acquired pulmonary diseases may 
also result from genetic lesions as in the subset of pulmonary 
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carcinomas associated with mutations in tumor suppressor 
genes (5-7). Also in this instance, reversal of the abnormal 
phenotype has been demonstrated in vitro by correction of 
the defective gene function (8). 
Gene-based therapies as an approach to these disorders 
will require development of gene transfer vectors capable of 
safe and effective delivery of DNA to the cells of the respira-
tory epithelium. A variety of DNA-mediated gene transfer 
vectors have been utilized to accomplish gene transfer to the 
respiratory epithelium in vitro and in vivo (9, 10). These vec-
tor Systems, however, are generally of very low efficiency. In 
addition, they are associated with significant cellular toxic-
ity. Recombinant viral vectors have also been utilized in this 
context (3, 11). Although more efficient, these agents suffer 
from limitations related to the size and design of DNA that 
can be transferred. In addition, potential safety hazards de-
rive from the obligatory co-transfer of elements of the parent 
virus genome. 
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As an alternative strategy that circumvents both sets of 
limitations, gene transfer has been accomplished via the 
receptor-mediated endocytosis pathway utilizing polycation-
ligand conjugates (12-14). These synthetic molecules pos-
sess two functional domains: a cognate moiety for a cell sur-
face receptor, which is covalently linked to a DNA-binding 
moiety, such as a cationic polyamine. Interaction of the DNA 
with the molecular conjugate serves to condense the DNA 
into compact, ligand-coated particles. When recognized by 
the appropriate cell surface receptor, the conjugate is inter-
nalized by the efficient receptor-mediated pathway, co-
transporting the complexed DNA. In the present study, we 
demonstrate that gene transfer to the respiratory epithelium 
in vitro may be accomplished by the receptor-mediated endo-
cytosis pathway utilizing transferrin-polylysine conjugates. 
Because this method accomplishes gene transfer by capitaliz-
ing on a normal physiologic cellular pathway, it is potentially 
nontoxic, permitting the potential to administer DNA on a 
repetitive or continuous basis. Additionally, this strategy 
offers the potential to achieve cell-specific targeting of gene 
delivery by virtue of the flexibility of design of the molecular 
conjugate vector. 
Materials and Methods 
Formation of Conjugate-DNA Complexes 
Human transferrin-polylysine conjugates consisting of hu-
man transferrin covalently linked to poly(L-lysine) 190 were 
prepared as described (13,14). The plasmid pRSVL contain-
ing the Photinus pyralis luciferase gene under the control of 
the Rous-sarcoma virus long terminal repeat enhancer/pro-
moter was used as a reporter of gene tranfer (15). Purified 
pRSVL DNA (6 /ig) was diluted into 350 /il total volume 
NaCl 150 mM/Hepes 20 mM, pH 7.3 (HBS). Human 
transferrin-polylysine conjugate (12 /ig) in total volume 150 
/il HBS was combined with the DNA and incubated at room 
temperature for 30 min to form conjugate-DNA complexes. 
Cell Culture 
The human respiratory epithelial cell line HBE1 was used as 
a target for gene transfer by transferrin-polylysine con-
jugates. This cell line is derived from normal human airway 
epithelium as described (J. R. Yankaskas, personal commu-
nication). Cells were maintained in F12-7X medium (16). 
Control cell lines for transferrin-polylysine conjugate-medi-
ated gene transfer were the non-respiratory epithelial cell 
lines HeLa and KB. HeLa was maintained in Dulbecco's 
modified Eagle's medium/5% heat-inactivated fetal calf se-
rum/penicillin at 100 international units/ml//streptomycin at 
100 /ig/ml//2 mM glutamine. KB cells were grown in Eagle's 
minimal essential medium/10% heat-inactivated fetal calf 
serum/penicillin at 100 international units/ml//streptomy-
cin at 100 /ig/ml//10 mM nonessential amino acids/2 mM 
glutamine. 
Gene Transfer to Respiratory Epithelial Cells Utilizing 
Human Transferrin-Pblylysine Conjugates 
Gene transfer experiments were performed by seeding ap-
proximately 5 x 105 cells into 6-cm tissue culture dishes 
and allowing cells to achieve 50% confluency. For HBE1 
cells, 12 h prior to gene transfer experiments, medium was 
changed to F12-6X, which l acks human transferrin Supple-
ment. To evaluate gene transfer mediated by transferrin-
polylysine conjugates, conjugate-DNA complexes (500 /il) 
were added directly to tissue culture dishes containing the 
various target cells and incubated for 24 h at 37° C, 5% 
C02 . For gene transfer experiments to test for the require-
ment for receptor binding by individual conjugate compo-
nents, HBE1 cells were preincubated at 4° C prior to addi-
tion of complexes formed between pRSVL DNA and 
individual conjugate components. These were formed by ad-
dition of 6 /ig plasmid DNA to human transferrin (9 /ig) or 
polylysine (3 /ig) in amounts equimolar to transferrin-
polylysine conjugate (12 /ig). After addition of the com-
plexes, plates were incubated for 2 h at 4° C. This step al-
lowed specific receptor binding of the complexes without 
cellular internalization. Plates were then washed 3 times 
with ice-cold F12-7X medium to remove unbound compo-
nents in the medium, permitting determination of cellular in-
ternalization on the basis of specific receptor-mediated 
mechanisms. After the washing step, plates were gradually 
warmed up and returned to the incubator (37° C, 5% C02) 
for 24 addi t ional hours. For competition experiments to test 
for the specificity of the conjugates for the transferrin recep-
tor, cells were treated with hTfpL/pRSVL complexes in the 
presence of increasing amounts of human transferrin as a 
specific competitor for the transferrin receptor or bovine se-
rum albumin as a nonspecific competitor. After the addition 
of complexes and human transferrin or bovine serum albu-
min competitor, cells were incubated for 24 h (37° C, 5% 
C02). In experiments employing agents to augment cellular 
availability of transferred DNA, HBE1 cells were treated 
with 50 /iM desferrioxamine (Sigma Chemical Co., St. 
Louis, MO) or 100 /iM chloroquine (Sigma) alone or in 
combination. For desferrioxamine treatment, cells were 
pretreated with F12-6X medium containing desferrioxamine 
for 12 h prior to addition of complexes. For chloroquine 
treatment, cells were treated with chloroquine for 4 h during 
exposure to the hTfpL/pRSVL complexes. For both treat-
ments, 4 h after addition the conjugate-DNA complexes 
were removed, plates washed, and cells incubated for 24 h 
(37° C, 5% C02) in F12-7X medium. Analysis of gene 
transfer was accomplished by preparation of cellular lysate 
and evaluation for luciferase gene expression as described 
(14). Aliquots of cell lysate containing 50 /ig of total protein 
were analyzed. Results are expressed as "Light Units750 /ig 
total cellular protein. Experiments were performed 3 to 4 
times, and results expressed as mean ± SEM. 
Results 
In Vitro Gene Transfer to Respiratory Epithelial Cells 
Mediated by Transferrin-Folylysine Conjugates 
To determine the feasibility of gene transfer via the receptor-
mediated endocytosis pathway (Figure 1) in respiratory epi-
thelial cells, the respiratory epithelial cell line HBE1 was 
used as a target for transduction by transferrin-polylysine 
conjugates. As a comparison, the non-respiratory epithelial 
cell lines HeLa and KB were analyzed in parallel (Figure 2). 
For HBE1 cells, application of conjugate-DNA complexes 
containing the luciferase reporter gene resulted in levels of 
reporter gene activity significantly greater than background 
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Figure 1. Strategy for gene transfer via the trans-
ferrin internalization pathway utilizing transferrin-
polylysine conjugates. Interaction of plasmid DNA 
with human transferrin-polylysine conjugates 
results in the formation of conjugate-DNA com-
plexes in which the DNA is Condensed into com-
pact transferrin-coated particles. The transferrin 
moiety of the complex binds to cellular receptors 
for transferrin, allowing the internalization of the 
complex by the receptor-mediated endocytosis 
pathway. After internalization, the transferred 
DNA is localized within the endosomes, where-
upon it is either targeted for lysosomal degrada-
tion, or alternatively, achieves escape from the en-
dosome to reach the nucleus, where foreign gene 
expression is effected. 
levels in untreated HBE1 cells (P < 0.005). This level of gene 
expression was greater than levels exhibited by non-respira-
tory epithelial cell lines that are characterized by high num-
bers of cell surface transferrin receptors (17). 
Consistent with the concept that internalized conjugate-
DNA complex has different intracellular fates in different 
target cells, KB cells demonstrated minimal susceptibility to 
gene transfer by transferrin-polylysine conjugates despite the 
presence of high levels of transferrin receptors. In this re-
gard, it has been hypothesized that the phenomenon of 
limited gene transfer by molecular conjugates in the context 
of appropriate cell surface receptors is due to lysosomal tar-
geting of the DNA (18). Thus, the use of lysosomatropic 
agents, such as chloroquine, can very significantly augment 
levels of gene expression mediated by molecular conjugate 
HeLa KB HBE1 
Figure 2. Gene transfer to respiratory epithelial cells in vitro 
mediated by transferrin-polylysine conjugates. The normal respira-
tory epithelial cell line HBE1 as well as the non-respiratory epithe-
lial cell lines HeLa and KB were treated with conjugate-DNA com-
plexes consisting of human transferrin-polylysine (12 /ig) plus the 
reporter plasmid pRSVL (6 /ig), which contains the Photinus 
pyralis luciferase gene. After 24 h of incubation (37° C, 5% 
C02), cell lysates were prepared. Aliquots of cell lysate contain-
ing 50 /ig total protein were assayed for luciferase gene expression 
by luminometry. Results are expressed as Light Units/50 /ig total 
cellular protein. Background indicates luciferase activity in un-
treated control cells. Experiments were performed 3 to 4 times, and 
results represent mean ± SEM. 
vectors in these instances (14, 18). For KB cells, augmented 
gene expression can be demonstrated with the addition of 
chloroquine (data not shown). In contrast, for the respira-
tory epithelial cell line HBE1, transferrin-polylysine con-
jugates alone appear to effect significant levels of foreign 
gene expression. Thus, gene transfer to respiratory epithelial 
cells in vitro may be accomplished by transferrin-polylysine 
conjugates. Additionally, the baseline susceptibility of respi-
ratory epithelial cells to gene transfer by this vector appears 
to be as great or greater than that of cell lines known to pos-
sess large numbers of receptors for the conjugate ligand. 
Mechanism of Gene Transfer to Respiratory Epithelial 
Cells Mediated by Transfenin-Folylysine Conjugates 
To determine the mechanism of gene transfer to respiratory 
epithelial cells mediated by transferrin-polylysine conju-
gates, the contribution of each functional domain of the con-
jugate molecule in effecting gene transfer was evaluated. 
Reporter plasmid DNA pRSVL alone, or in combination 
with polylysine or transferrin, or in combination with trans-
ferrin-polylysine conjugate, was evaluated for the ability to 
accomplish gene transfer after specific binding to the target 
HBE1 cells (Figure 3A). In this analysis, complexes consist-
ing of the plasmid DNA plus the transferrin-polylysine con-
jugate mediated levels of reporter gene expression signifi-
cantly greater than did complexes containing pRSVL in 
combination with individual complex components, polyly-
sine or transferrin (P < 0.05). This result is consistent with 
the concept that gene transfer mediated by conjugate vectors 
requires fiinctional domains capable of both DNA binding 
and cell-surface receptor recognition. 
To test whether the cellular internalization mediated by 
the transferrin-polylysine conjugates was indeed by the trans-
ferrin pathway, gene transfer employing the transferrin-
polylysine conjugates was carried out in the presence of 
competition for the transferrin cell surface receptor (Figure 
3B). In these experiments, increasing competition for the 
transferrin receptor by exogenous human transferrin resulted 
in a marked attenuation of gene transfer mediated by the 
transferrin-polylysine conjugates (P < 0.001). Competition 
with comparable amounts of an irrelevant protein, bovine se-
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Figure 3. Mechanism of gene transfer to respiratory epithelial 
cells mediated by transferrin-polylysine conjugates. Panel A: Gene 
transfer mediated by complexes formed with conjugate compo-
nents. Complexes were formed by combination of 6 /ig pRSVL 
plasmid DNA with 9 /ig human transferrin (hTf) or 3 /ig polylysine 
(pL) in amounts equimolar to 12 /ig transferrin-polylysine con-
jugates (hTfpL). Specific binding of the formed complexes was 
achieved by addition to HBE1 cells with incubation at 4° C for 2 h 
followed by extensive washing to eliminate unbound, fluid-phase 
components. Plates were then incubated at 37° C for an additional 
24 h. Panel B: Effect of competition for transferrin receptor on gene 
transfer by transferrin-polylysine conjugates. Conjugate-DNA com-
plexes consisting of 6 /ig pRSVL DNA and 12 /ig human 
transferrin-polylysine conjugate were added to HBE1 cells in the 
presence of increasing concentrations of human transferrin. 
Panel C: Effect of specific and nonspecific competition for transfer-
rin receptor on gene transfer by transferrin-polylysine conjugates. 
Conjugate-DNA complexes consisting of 6 /ig pRSVL DNA and 
rum albumin, did not exert a significant effect on gene trans-
fer mediated by the conjugates (Figure 3C). These findings 
confirm that respiratory epithelial cells possess receptors for 
transferrin and that gene transfer to these cells may be ac-
complished by the transferrin internalization pathway utiliz-
ing transferrin-polylysine conjugates. 
Augmentation of Gene Transfer via the Transferrin 
Pathway Utilizing Agents that Increase Entry 
and Survival of DNA 
Gene transfer mediated by transferrin-polylysine conjugates 
may be augmented by agents that enhance DNA availability 
to target cells. In cells of hematopoietic lineage, enhanced 
gene transfer via the transferrin pathway has been achieved 
utilizing agents that either increase cell surface transferrin 
receptors or decrease the intracellular degradation of inter-
nalized DNA (18). Similar strategies were evaluated in cells 
of the respiratory epithelium (Figure 4). Treatment of HBE1 
cells with chloroquine, an agent that inhibits lysosomal deg-
radative processes, resulted in a significant augmentation of 
gene transfer by the transferrin-polylysine conjugates com-
pared with treatment with the conjugates alone (P < 0.005). 
This is consistent with the concept that increasing the frac-
tion of internalized DNA that avoids lysosomal destruction 
will allow a corresponding increase in the fraction that sur-
vives to effect heterologous gene expression. Treatment of 
cells with desferrioxamine prior to conjugate addition to 
augment cell surface transferrin receptor numbers, however, 
did not augment gene expression levels over conjugate addi-
tion at baseline. This suggests that augmented internaliza-
tion, in the absence of agents that inhibit degradation of the 
internalized DNA, is not sufficient in itself to enhance effec-
tive gene transfer by this pathway. In contrast, however, treat-
ment with both desferrioxamine and chloroquine resulted in 
levels of reporter gene expression significantly greater than 
those achieved by treatment with chloroquine alone (P < 
0.005). This suggests that augmented conjugate entry is 
effective only in the context whereby lysosomal degradation 
of the internalized DNA is inhibited. 
Discussion 
The potential to achieve genetic correction of a variety of in-
herited and acquired disease processes affecting the cells of 
the airway epithelium establishes the necessity of developing 
vectors to accomplish effective gene transfer to these cells. 
Because of the nature of the pulmonary architecture, how-
ever, it is unlikely this can be accomplished by conventional 
gene therapy strategies (19-22), which involve harvesting of 
the affected cells followed by extracorporeal genetic modifi-
cation and reimplantation. Thus, for the cells of the respira-
tory epithelium, delivery of the therapeutic genetic material 
will most likely require direct, in vivo delivery by the gene 
transfer vector. 
12 /ig human transferrin-polylysine conjugate (KTfpL) were added 
to HBE1 cells in the presence of human transferrin (hTf) (1.0 
mg/ml), as a specific competitor for the transferrin receptor, or bo-
vine serum albumin (BSA) (1.0 mg/ml), as a nonspecific com-
petitor. 
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Figure 4. Effect of agents that augment cellular availability of 
DNA on gene transfer by transferrin-polylysine conjugates. To aug-
ment gene transfer mediated by transferrin-polylysine DNA com-
plexes, HBE1 cells were treated with desferrioxamine (50 /iM) 
and/or chloroquine (100 /iM). 
Presently available gene transfer vectors are not well 
suited to accomplish direct gene transfer to the respiratory 
epithelium in vivo. The various DNA-mediated and fusion 
methods are of relatively low efficiency and associated with 
cell toxicity. Despite these drawbacks, direct, in vivo gene 
transfer to the lung has been reported utilizing cationic lipo-
somes (10, 23). Recombinant viral vectors have been shown 
to possess higher efficiency gene transfer capacity to airway 
epithelia in both the in vitro and in vivo contexts (3, 11). De-
spite this advantage, however, these agents suffer drawbacks 
related to the issue of their safety in the context of direct in 
vivo delivery. In this regard, both recombinant adenovirus 
and retrovirus vectors mediate obligatory co-delivery of vi-
ral gene elements with transfer of the heterologous gene. 
Gene transfer via the receptor-mediated endocytosis 
pathway utilizing ligand conjugates offers several advantages 
for ultimate employment as an in vivo gene transfer vector. 
The cellular internalization of the conjugate is via a Physio-
logie cellular pathway and is thus not likely associated with 
the cytotoxicity consequent to plasma membrane transition 
mechanisms of the DNA-mediated and fusion methods (24, 
25). As the conjugates interact with DNA in a sequence-
independent manner, there are no restrictions on the design 
of the transferred DNA construet (13, 14). Thus, viral gene 
elements are not an essential feature, thereby obviating safety 
hazards deriving from their incorporation. An additional 
feature of potential Utility is that conjugates may be designed 
that allow the possibility of cell-specific targeting based upon 
the ligand moiety's speeificity. In this regard, cell-specific 
targeting in vivo has been reported utilizing molecular con-
jugate gene transfer vectors (26, 27). 
The design of molecular conjugate vectors capable of 
achieving cell-specific targeting to the lung will require cell 
surface receptors unique to the respiratory epithelium. The 
first step in polycation-ligand conjugate-mediated gene 
transfer is the recognition of a cell-surface receptor by the 
ligand portion of the conjugate-DNA complex. For respi-
ratory epithelium, cell-specific receptors have not been de-
lineated, and thus more generalized cell surface receptors 
were considered in the present study. Transferrin receptors 
have a wide distribution in a variety of tissue types (17, 28). 
Thus, this study employed transferrin-polylysine conjugates 
to evaluate the feasibility of this type of approach for cells 
of the respiratory epithelium. It is axiomatic that the delinea-
tion of respiratory epithelium-speeifie receptors will allow 
the design of conjugate vectors capable of exploiting this en-
try route to achieve gene transfer to selective cell subsets of 
the respiratory epithelium. 
The feasibility of utilizing transferrin-polylysine con-
jugates for in vivo gene transfer to the respiratory epithelium 
remains to be established. The intracellular fate of internal-
ized conjugate-DNA complexes may be different for immor-
talized respiratory epithelial cell lines and intact airway epi-
thelium in situ, potentially limiting the efficiency of gene 
transfer by the transferrin pathway. In addition, the distribu-
tion of transferrin receptors in airway epithelial cell subsets 
has not been delineated. Studies of a variety of non-respira-
tory epithelial tissues have demonstrated transferrin receptor 
localization within basal cell layers (28), consistent with the 
concept that transferrin receptor distribution correlates with 
the State of cellular proliferation (29). Similar localization 
of transferrin receptors to the airway epithelial basal cell 
subset would dictate a systemic route of administration of the 
conjugates to target these cells. Alternatively, localization of 
transferrin receptors at the apical pole of luminal respiratory 
epithelial cells would permit airway delivery of the con-
jugates. In this regard, transferrin levels in the epithelial 
lining fluid of the lung are enriched relative to serum, sug-
gesting facilitated transport or local produetion (30). Local-
ization of transferrin to the airway lumen suggests co-
localization of the corresponding cell surface receptor, thus 
potentially allowing the delivery of transferrin-polylysine 
conjugates by the airway route. 
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